1302 The therapeutic effect of glycolysis inhibition in lupus-prone mice is transferable through the fecal microbiome

Bibliographic Details
Main Authors: Laurence Morel, Seung-Chul Choi, Josephine Brown, Georges Abboud, Ahmed S Elshikha, Yong Ge, Nathalie Kanda, Timothy J Garrett, William Clapp, Mansour Zadeh
Format: Article
Language:English
Published: BMJ Publishing Group 2022-12-01
Series:Lupus Science and Medicine
_version_ 1811199554677112832
author Laurence Morel
Seung-Chul Choi
Josephine Brown
Georges Abboud
Ahmed S Elshikha
Yong Ge
Nathalie Kanda
Timothy J Garrett
William Clapp
Mansour Zadeh
author_facet Laurence Morel
Seung-Chul Choi
Josephine Brown
Georges Abboud
Ahmed S Elshikha
Yong Ge
Nathalie Kanda
Timothy J Garrett
William Clapp
Mansour Zadeh
author_sort Laurence Morel
collection DOAJ
first_indexed 2024-04-12T01:49:35Z
format Article
id doaj.art-96f9123f909046638b896a1f03eb17cb
institution Directory Open Access Journal
issn 2053-8790
language English
last_indexed 2024-04-12T01:49:35Z
publishDate 2022-12-01
publisher BMJ Publishing Group
record_format Article
series Lupus Science and Medicine
spelling doaj.art-96f9123f909046638b896a1f03eb17cb2022-12-22T03:52:58ZengBMJ Publishing GroupLupus Science and Medicine2053-87902022-12-019Suppl 310.1136/lupus-2022-lupus21century.921302 The therapeutic effect of glycolysis inhibition in lupus-prone mice is transferable through the fecal microbiomeLaurence Morel0Seung-Chul Choi1Josephine Brown2Georges Abboud3Ahmed S Elshikha4Yong Ge5Nathalie Kanda6Timothy J Garrett7William Clapp8Mansour Zadeh9Pathology, Immunology, and Laboratory Medicine, University of Florida, Gainesville, Florida, USADepartment of Pathology, Immunology and Laboratory Medicine, University of Florida, Gainesville, FL, USADepartment of Pathology, Immunology and Laboratory Medicine, University of Florida, Gainesville, FL, USA2Department of Pathology, Immunology, and Laboratory Medicine, University of Florida, Gainesville, FL, USA1Department of Pathology, Immunology, and Laboratory Medicine, University of Florida, Gainesville, Fl., USA2Department of Microbiology, Immunology, and Molecular Genetics, University of Texas Health San Antonio, Tx., USA2Department of Microbiology, Immunology, and Molecular Genetics, University of Texas Health San Antonio, Tx., USA1Department of Pathology, Immunology, and Laboratory Medicine, University of Florida, Gainesville, Fl., USA1Department of Pathology, Immunology, and Laboratory Medicine, University of Florida, Gainesville, Fl., USA2Department of Microbiology, Immunology, and Molecular Genetics, University of Texas Health San Antonio, Tx., USA
spellingShingle Laurence Morel
Seung-Chul Choi
Josephine Brown
Georges Abboud
Ahmed S Elshikha
Yong Ge
Nathalie Kanda
Timothy J Garrett
William Clapp
Mansour Zadeh
1302 The therapeutic effect of glycolysis inhibition in lupus-prone mice is transferable through the fecal microbiome
Lupus Science and Medicine
title 1302 The therapeutic effect of glycolysis inhibition in lupus-prone mice is transferable through the fecal microbiome
title_full 1302 The therapeutic effect of glycolysis inhibition in lupus-prone mice is transferable through the fecal microbiome
title_fullStr 1302 The therapeutic effect of glycolysis inhibition in lupus-prone mice is transferable through the fecal microbiome
title_full_unstemmed 1302 The therapeutic effect of glycolysis inhibition in lupus-prone mice is transferable through the fecal microbiome
title_short 1302 The therapeutic effect of glycolysis inhibition in lupus-prone mice is transferable through the fecal microbiome
title_sort 1302 the therapeutic effect of glycolysis inhibition in lupus prone mice is transferable through the fecal microbiome
work_keys_str_mv AT laurencemorel 1302thetherapeuticeffectofglycolysisinhibitioninlupuspronemiceistransferablethroughthefecalmicrobiome
AT seungchulchoi 1302thetherapeuticeffectofglycolysisinhibitioninlupuspronemiceistransferablethroughthefecalmicrobiome
AT josephinebrown 1302thetherapeuticeffectofglycolysisinhibitioninlupuspronemiceistransferablethroughthefecalmicrobiome
AT georgesabboud 1302thetherapeuticeffectofglycolysisinhibitioninlupuspronemiceistransferablethroughthefecalmicrobiome
AT ahmedselshikha 1302thetherapeuticeffectofglycolysisinhibitioninlupuspronemiceistransferablethroughthefecalmicrobiome
AT yongge 1302thetherapeuticeffectofglycolysisinhibitioninlupuspronemiceistransferablethroughthefecalmicrobiome
AT nathaliekanda 1302thetherapeuticeffectofglycolysisinhibitioninlupuspronemiceistransferablethroughthefecalmicrobiome
AT timothyjgarrett 1302thetherapeuticeffectofglycolysisinhibitioninlupuspronemiceistransferablethroughthefecalmicrobiome
AT williamclapp 1302thetherapeuticeffectofglycolysisinhibitioninlupuspronemiceistransferablethroughthefecalmicrobiome
AT mansourzadeh 1302thetherapeuticeffectofglycolysisinhibitioninlupuspronemiceistransferablethroughthefecalmicrobiome